Should the terminally ill have the right to try risky, non FDA approved drugs?
April 30, 2015
What do you think about these questions? Let us know in the comments and check out the extended version here: http://youtu.be/bV2idyygYzk
The FDA approval process can take years, and thousands of terminally ill patients die every year waiting to the FDA to approve potentially life-saving drugs. Should terminally ill patients suffering from serious diseases like cancer have the right to try risky, non FDA approved drugs? If patients with terminal illnesses can try experimental drugs, what about patients who are sick, but not terminally ill? Economics Professor Howard Baetjer went to Towson University in Baltimore, Maryland to ask students what they think about these tough questions.
You can check out the extended cut of the video, with additional commentary from Professor Baetjer on the FDA approval process, here: http://youtu.be/bV2idyygYzk